Access to nuclear technologies is critical for countries around the world. Besides the use of nuclear technologies for medicine, irradiation of single use medical devices, food pasteurization and phytosanitary treatments constitute the other major application of nuclear technologies. Cobalt-60 is the legacy industrial irradiation technology all around the world. Due to the increasing costs of cobalt-60, the projected short supply of the isotope, the tightening restrictions on transboundary shipment of cobalt-60, and the security risks radioactive cobalt-60 can pose, there is a growing interest in a deeper understanding and commercial adoption of accelerator technologies such as eBeam and X-ray in member states. Feasibility studies play a crucial role in establishing the technical specifications of equipment and identifying key users for installed technologies. In this presentation, we will delve into valuable insights gained from feasibility studies conducted in both Asia and South America. The discussion will focus on recognizing traditional and non-traditional stakeholders essential for participation in these studies, and it will outline the methods used to compute capital and operating costs, along with the calculation of return on investment. Emphasis will be placed on the significance of selecting an optimal location for an eBeam facility, with attention to potential conflicts between private end-users and government stakeholders and how these decisions could have major implications on securing funding.